425: Strive Updates on Semler Scientific Merger

Strive, Inc. posted a communication on X.com regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and where to find additional information.

Summary

• Strive, Inc. (Strive) posted a communication on X.com on October 10, 2025, concerning its proposed business combination with Semler Scientific, Inc. (Semler Scientific).
• The communication primarily serves as a cautionary statement regarding forward-looking statements related to the merger.
• It highlights that the proposed transaction involves inherent risks and uncertainties, which could cause actual results to differ materially from anticipated results.
• Key areas of forward-looking statements include the outlook and expectations of both companies, strategic and financial benefits, timing of closing, and integration success.
• Investors are advised to read the Registration Statement on Form S-4, Information Statement/Proxy Statement/Prospectus, and other relevant SEC filings for important information.
• The communication explicitly states it is not an offer to sell securities or a solicitation of votes.

Sentiment

Score: 5

Explanation: The filing is a neutral, procedural communication regarding a proposed merger, primarily serving as a cautionary statement about forward-looking information and associated risks. It does not present new financial results or operational updates.

Positives

• Companies are actively communicating about the proposed business combination.
• Strive intends to file a Registration Statement on Form S-4, which will include detailed information for investors, promoting transparency.

Negatives

• The proposed transaction is subject to inherent risks and uncertainties that could cause actual results to differ materially from expectations.
• Potential for the proposed transaction not to close as expected or at all.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• Diversion of management's attention from ongoing business operations.
• Potential for dilution due to Strive's issuance of Class A common stock.
• Possible adverse reactions from customers or changes to business/employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.

Risks

• Occurrence of any event, change, or circumstance that could give rise to the right of one or both parties to terminate the merger agreement.
• Possibility that the proposed transaction does not close when expected or at all due to conditions not being met.
• Outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• Anticipated benefits (cost savings, strategic gains) may not be realized, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• Proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing contains forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific with respect to the proposed transaction, including strategic and financial benefits, timing of closing, and successful integration of businesses. However, these are subject to significant risks and uncertainties that could cause actual results to differ materially from anticipated results.

Industry Context

This communication is a standard regulatory disclosure in the context of a proposed business combination, common across industries for publicly traded companies undergoing significant corporate actions. It emphasizes the legal requirements for transparency regarding forward-looking statements and associated risks during such transactions.

Legal Proceedings

• The filing mentions the possibility that legal proceedings may be instituted against Strive or Semler Scientific or the combined company as a risk factor related to the proposed transaction.

Stakeholder Impact

• Shareholders: Potential for dilution due to Strive's issuance of Class A common stock; urged to read detailed merger documents for informed voting and investment decisions.
• Customers: Potential for adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Employees: Potential for changes to employee relationships resulting from the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with other relevant SEC documents.

Key Dates

Recommendation

This filing is a standard regulatory communication (Form 425) related to an already announced proposed business combination between Strive and Semler Scientific. It primarily serves as a cautionary statement regarding forward-looking information and outlines where investors can find more detailed merger documents. It does not contain new financial results, operational updates, or strategic shifts that would alter an investment recommendation. Therefore, a 'hold' recommendation is appropriate as investors should await the full S-4 filing for comprehensive details before making further investment decisions.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Bitcoin Treasury Strategy, Digital Assets